Who Owns Relay Therapeutics Stock?
NASDAQ: RLAYHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 110.87%
- Institutions (% of float)
- 112.64%
- Held by insiders
- 1.58%
- Institutional holders
- 349
- Institutions 98.4%
- Insiders 1.6%
- Public and other 0.0%
Who owns Relay Therapeutics stock?
Institutional investors own about 110.9% of Relay Therapeutics's shares, spread across 349 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.58% of RLAY.
The largest institutional holders are SB Investment Advisers (UK) LTD (12.73%), FMR, LLC (9.18%) and Casdin Capital, LLC (7.32%). Together, the top 10 institutions control 63.4% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their RLAY positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RLAY
| Institution | Shares | % Held | Change |
|---|---|---|---|
| SB Investment Advisers (UK) LTD | 27.90M | 12.73% | 0.0% |
| FMR, LLC | 20.11M | 9.18% | +444.2% |
| Casdin Capital, LLC | 16.04M | 7.32% | +11.2% |
| Blackrock Inc. | 15.29M | 6.98% | +17.8% |
| Perceptive Advisors Llc | 14.11M | 6.44% | +44.7% |
| Commodore Capital Lp | 12.00M | 5.48% | -29.4% |
| State Street Corporation | 10.13M | 4.62% | +62.4% |
| Vanguard Capital Management LLC | 8.96M | 4.09% | +21.4% |
| Price (T.Rowe) Associates Inc | 7.71M | 3.52% | +300.4% |
| Nextech Invest, Ltd. | 6.78M | 3.09% | +22.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RLAY
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 6.80M | 3.10% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 6.64M | 3.03% |
| iShares Trust-iShares Russell 2000 ETF | 4.15M | 1.89% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 2.08M | 0.95% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.94M | 0.89% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.94M | 0.89% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.92M | 0.88% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 1.85M | 0.84% |
| T. Rowe Price Health Sciences Fund, Inc. | 1.84M | 0.84% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.77M | 0.81% |
Frequently asked questions
Who is the largest shareholder of Relay Therapeutics?
SB Investment Advisers (UK) LTD is the largest institutional shareholder of RLAY, owning 12.73% of shares outstanding (27.90M shares) as of its latest 13F filing.
What percentage of Relay Therapeutics is owned by institutions?
Institutions own about 110.9% of RLAY shares and 112.6% of the public float.
How much of Relay Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.58% of RLAY shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.